These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6778186

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction.
    Rydén L, Arnman K, Conradson TB, Hofvendahl S, Mortensen O, Smedgård P.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1006-12. PubMed ID: 6778187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tocainide for refractory ventricular arrhythmias of myocardial infarction.
    Haffajee CI, Alpert JS, Dalen JE.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1013-6. PubMed ID: 6778188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular arrhythmias.
    Sonnhag C.
    Eur J Clin Pharmacol; 1980 Oct; 18(4):301-10. PubMed ID: 6777178
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B, Bakshi M, Branagan P, Kelly JG, Walsh MJ.
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide.
    Ikram H.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1076-80. PubMed ID: 6108707
    [Abstract] [Full Text] [Related]

  • 14. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [Abstract] [Full Text] [Related]

  • 15. Treatment of ventricular arrhythmias with oral tocainide.
    Young MD, Hadidian Z, Horn HR, Johnson JL, Vassallo HG.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1041-5. PubMed ID: 6778193
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction.
    Graffner C, Conradson TB, Hofvendahl S, Rydén L.
    Clin Pharmacol Ther; 1980 Jan; 27(1):64-71. PubMed ID: 7351118
    [Abstract] [Full Text] [Related]

  • 18. Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.
    Maloney JD, Nissen RG, McColgan JM.
    Am Heart J; 1980 Dec; 100(6 Pt 2):1023-30. PubMed ID: 6778190
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.